Thank you very much, Mr. Chair.
Three minutes are very short and I'm going to jump in right away with you, Mr. Nickerson.
First, thank you for being here. It's nice to see you again.
You talked about the lessons learned with regard to vaccine equity, with regard to access to essential medicines. Have the lessons been learned by Canada? I mean, we haven't agreed to the TRIPS waiver. What has changed? If we have another COVID-19 tomorrow, would there be any difference in what would happen this time around?